Latin American Center for Emerging Infectious Disease Surveillance and Readiness
Official title: Latin American Center for Emerging Infectious Disease Research (LACER)
Funded at University of California at Davis · NIH-11601583 · Data updated 2026-11-12
A regional collaboration in Peru and neighboring countries aims to strengthen early warning and monitoring for viruses that could jump from animals to people, helping communities prepare for outbreaks.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project start | September 21, 2026 |
| Project end | June 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $199,700 |
| NIH project number | 3U01AI190394-01S2 |
| Project ID | NIH-11601583 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are people living in or traveling through areas where arboviruses and other zoonotic pathogens are being monitored, particularly in Peru and neighboring regions.
✕Less likely to help
People not in affected regions or not participating in surveillance activities may not directly benefit.
What this research studies
This grant supports a cross-border effort led by UC Davis with Peruvian partners to build real-time surveillance for viruses that threaten people in diverse ecological settings. The project focuses on high-risk arboviruses and other zoonotic pathogens, using a network that connects urban centers with remote areas. By mapping where pathogens are present and how they move through ecosystems, the team aims to enhance outbreak readiness and rapid response. The work combines public health officials, researchers, and NGOs to create practical, region-specific surveillance strategies that account for climate and land-use changes.
Why it matters
Potential benefit: If successful, communities could see faster detection of outbreaks and improved response to prevent disease spread.
How similar studies have gone: Similar regional surveillance networks have improved early detection and response in other settings, supporting the potential value of this approach.
Where this research is happening
-
University of California at Davis
Davis, United States Active
Researchers
- Principal investigator: Morrison, Amy Celeste — University of California at Davis
- Study coordinator: Morrison, Amy Celeste
Related research
Other NIH-funded projects on the same topics.
-
Center in Latin America to monitor emerging infectious diseases
A U01 grant supporting a collaboration between Peruvian and U.S. researchers to improve early detection and surveillance of regionally relevant viruses that could affect people, animals, and crops in Peru and neighboring areas.
-
Acanthamoeba as a modern model parasite to study infectious disease biology and mitochondria
A five-year project will define the mitochondrial proteins and pathways of Acanthamoeba castellanii to advance infectious disease biology and parasite metabolism.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
-
Multi-omic endotypes of vaccine response, respiratory infections, and asthma in children
A parent-friendly look at how early-life immune development shapes how kids respond to vaccines and stay free from lung infections and asthma, using advanced biological profiling.
-
IDEAL: How early-life immune development shapes vaccine responses and asthma risk
A child-focused project that looks at how the developing immune system in early life affects vaccine responses, respiratory infections, and asthma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.